Ad
related to: biogen
Search results
Biogen maintains stock target with Buy rating on acquisition intention By Investing.com
Investing.com· 5 days agoOn Wednesday, Biogen Inc (NASDAQ:BIIB) received confirmation from Stifel that its Buy rating and...
South Korea’s MFDS approves Eisai-Biogen’s LEQEMBI for Alzheimer’s
Pharmaceutical Technology via Yahoo Finance· 4 hours agoThe South Korean Ministry of Food and Drug Safety (MFDS) has granted approval for Eisai and Biogen’s...
Biogen shares maintain overweight rating By Investing.com
Investing.com· 5 days agoOn Wednesday, Morgan Stanley (NYSE:MS) maintained its positive stance on Biogen (NASDAQ:BIIB), the...
Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal
CNBC· 5 days agoBiogen said on Wednesday it had agreed to buy privately held Human Immunology Biosciences for up to...
Biogen to Pay Up to $1.8 Billion for Immune Drug Developer
Bloomberg· 5 days agoHave a confidential tip for our reporters? Biogen Inc. agreed to acquire Human Immunology...
Pomerantz Law Firm Announces the Filing of a Class Action Against Biogen Inc. and Certain Officers -...
KTLA-TV Los Angeles· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the"Company") (NASDAQ: BIIB) and certain officers. The ...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to...
FOX 23 News Albany· 4 days agoThe Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
Biogen, looking to diversify, acquires immune drugmaker HI-Bio for $1.15B
BioPharma Dive via Yahoo Finance· 5 days agoThe deal, only Biogen’s third since the start of 2018, is a sign the company is open to branching...
Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 3 days agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have added about...
...INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Biogen Inc. Investors with...
Morningstar· 4 days agoThe law firm ofRobbins Geller Rudman & Dowd LLP announces that the Biogen class action lawsuit seeks to represent purchasers or acquirers of Biogen Inc.
